SHILPA MEDICARE LTD. - Share Price | Related News | BSE/NSE Performance | Live Stock Quote

Rediff Moneywiz

Hi Guest
Feedback

Announcements

for Shilpa Medicare Ltd.

16 May	Board to consider FY22 Results & Dividend on May 23, 2022
16 May	Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
02 May	US FDA Inspection Of Shilpa Medicare Limited, Unit VII, Analytical Services Division
26 Apr	Notice Of The National Company Law Tribunal (Tribunal) Convened Meeting Of The Equity Shareholders, Secured Creditors And Trade Creditors Of The Company.
25 Apr	Notice Of The National Company Law Appellate Tribunal (Tribunal) Convened Meeting Of The Equity Shareholders Of The Company.
25 Apr	Shilpa Medicare Limited (SML) Receives Noc From RCGM, Dept. Of Biotechnology For Its Biosimilar Aflibercept - Intimation U/R 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
23 Apr	Submission In Compliance With Regulation 76 Of The Securities And Exchange Board Of India (Depositories And Participants) Regulations, 2018 For Quarter And Financial Year Ended 31 March, 2022.
23 Apr	Disclosure For Non Applicability As Large Entity: SEBI Circular No SEBI/HO/DDHS/CIR/P/2018/144, Dated November 26, 2018
23 Apr	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
23 Apr	Sub: Submission In Compliance With Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Financial Year Ended 31 March, 2022.

View announcements for all companies

Next >

Mutual Fund Selector

Find the fund that is right for you

ALL MONEYWIZ PAGES